TNF and rheumatoid arthritis: Similar to AS, increased baseline NLR levels were found to determine the 12-week treatment response to TNF-α blockers in RA patients in a study by Lee et al. [7] Taken together, we believe that NLR may serve as a parameter for monitoring and predicting the therapeutic response to TNF-α blockers in patients with inflammatory rheumatic diseases, including AS.